United States· US:0299-3848_a9ce2f1a-7cba-4759-ac1d-7638cf99c7be
Clobex
A medicinal product containing clobetasol propionate, registered in United States by Galderma Laboratories, L.P..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- Clobetasol Propionate
- Manufacturer
- Galderma Laboratories, L.P.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- June 3, 2026
Packs & prices · 2
- ndc1102993848021 BOTTLE in 1 CARTON (0299-3848-02) / 59 mL in 1 BOTTLE
- ndc1102993848041 BOTTLE in 1 CARTON (0299-3848-04) / 118 mL in 1 BOTTLE
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Clobetasol propionate in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NorwayDermovatGlaxoSmithKline AS
- United KingdomClarelux 500micrograms/g foamPierre Fabre Ltd
- PolandClareluxPierre Fabre Medicament
- CzechiaCLARELUXPIERRE FABRE MEDICAMENT, Lavaur
- CanadaCLOBEX SHAMPOOGALDERMA CANADA INC
- NetherlandsClarelux 500 microgram/g schuim voor cutaan gebruik in spuitbusEuro Registratie Collectief B.V.
- SwitzerlandClarelux
- Japanクロベタゾールプロピオン酸エステル岩城製薬
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Clarelux, Clobex
- Belgium · Cabesol, Clarelux
- Bulgaria · Дермоват, Инфилеа
- Cyprus · Dermovate, Medodermone
- Czechia · Clarelux, Clobetasol Belupo
- Germany · Clarelux, Clobegalen
- Denmark · Clobetasol Propionate Ifc, Clobetasolpropionat
- Estonia · Dermovate, Dermovate Ointment
- Spain · Clarelux, Clobex
- Finland · Clobex, Dermovat
- France · Cabesol, Clarelux
- United Kingdom (Northern Ireland) · Clarelux, Clobaderm
- Greece · Butavate, Clarelux
- Croatia · Cutibel
- Hungary · Clobex, Closanasol
- Ireland · Dermovate, Dermovate Scalp Application
- Iceland · Clobex, Dermovat
- Italy · Clobecare, Clobesol
- Lithuania · Closanasol, Dermovate
- Luxembourg · Cabesol, Clarelux
- Malta · Clobex, Dermovate
- Netherlands · Clarelux, Clobetasol Substipharm
- Norway · Clobex, Dermovat
- Poland · Clarelux, Clobederm
- Portugal · Clarelux, Clobetasol Basi
- Romania · Clobetasol Mk, Clobetazol Atb
- Sweden · Clobetasol Teva, Clobex
- Slovenia · Klobetazol Belupo
- Slovakia · Clarelux, Clobetasol Belupo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cd1b270b-26d6-41e6-aa07-7f254cc1b6e1 GET /v1/drugs/cd1b270b-26d6-41e6-aa07-7f254cc1b6e1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"productid": "0299-3848_a9ce2f1a-7cba-4759-ac1d-7638cf99c7be",
"productndc": "0299-3848",
"dosage_form": "LOTION",
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "CLOBETASOL PROPIONATE",
"proprietary_name": "Clobex",
"active_ingred_unit": "g/100mL",
"application_number": "NDA021535",
"marketing_category": "NDA",
"nonproprietary_name": "Clobetasol Propionate",
"start_marketing_date": "20030801",
"active_numerator_strength": ".05"
}See everything about clobetasol propionate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.